Results 191 to 195 of about 22,968 (195)

P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy

Cancer Letters, 2019
Borja Belandia, Maria J Ruiz-Hidalgo, Ricardo Sanchez-Prieto   +2 more
exaly  

Palbociclib and Fulvestrant in Breast Cancer

New England Journal of Medicine, 2019
Atul Batra
exaly  

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

Annals of Oncology, 2018
exaly  

Changes in clonal dynamics predict response to palbociclib

Nature Reviews Clinical Oncology, 2018
exaly  

Palbociclib

Reactions Weekly, 2016
openaire   +1 more source